The scRNA-seq analysis revealed that candidate Siglec-9 ligands CD59, CD47, and LGAL3BP were expressed in tumor cells in metastatic tumor tissues derived from patients with CRPC (Figure 6C). The gene discussed is CD59; the disease is neoplasm.